Subscribe To
PASG / Passage Bio Undervalued On Price, Long-Term Gene Therapy Prospects
PASG News
By GlobeNewsWire
April 17, 2023
Passage Bio to Present at Chardan's 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
PHILADELPHIA, April 17, 2023 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on developing tr more_horizontal
By Seeking Alpha
March 6, 2023
Passage Bio, Inc. (PASG) Q4 2022 Earnings Call Transcript
Passage Bio, Inc. (NASDAQ:PASG ) Q4 2022 Earnings Conference Call March 6, 2023 8:30 AM ET Company Participants Stuart Henderson - Vice President, Cor more_horizontal
By Seeking Alpha
February 28, 2023
Passage Bio Undervalued On Price, Long-Term Gene Therapy Prospects
Passage Bio's most advanced gene therapy reported good early Phase 1 data. Over $200 million in cash should provide funding until more data is availab more_horizontal
By GlobeNewsWire
February 27, 2023
Passage Bio to Report Fourth Quarter and Full-Year 2022 Financial Results on March 6, 2023
PHILADELPHIA, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on developing tra more_horizontal
By Seeking Alpha
August 6, 2022
Passage Bio, Inc. (PASG) CEO Edgar Cale on Q2 2022 Results - Earnings Call Transcript
Passage Bio, Inc. (NASDAQ:PASG ) Q2 2022 Earnings Conference Call August 4, 2022 8:30 AM ET Company Participants Stuart Henderson - VP of Corporate De more_horizontal
By Seeking Alpha
March 3, 2022
Passage Bio, Inc. (PASG) CEO Bruce Goldsmith on Q4 2021 Results - Earnings Call Transcript
Passage Bio, Inc. (PASG) CEO Bruce Goldsmith on Q4 2021 Results - Earnings Call Transcript more_horizontal
By Seeking Alpha
March 3, 2022
Passage Bio, Inc. (PASG) CEO Bruce Goldsmith on Q4 2021 Results - Earnings Call Transcript
Passage Bio, Inc. (PASG) CEO Bruce Goldsmith on Q4 2021 Results - Earnings Call Transcript more_horizontal
By Seeking Alpha
March 3, 2022
Passage Bio, Inc. (PASG) CEO Bruce Goldsmith on Q4 2021 Results - Earnings Call Transcript
Passage Bio, Inc. (PASG) CEO Bruce Goldsmith on Q4 2021 Results - Earnings Call Transcript more_horizontal